ReLeaf Medical Ltd.

www.releaf-med.com (under construction)

Formerly ReValve

High-Tech Company

Suspended Operations Q1/2013

Graduated from: Meytav

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2006
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

ReLeaf's technology platform will provide a therapeutic solution for a large number of patients with calcific aortic stenosis that are not treated otherwise and are not surgical candidates.

TECHNOLOGY

ReLeaf's propriety technology involves a unique integrated percutaneous catheter.

Products and Phases

Product	Phase
N/A
A medical device for treatment of a common heart condition that afflicts the elderly population, causing damage to the central arterial valve.

	TARGET MARKETS
	Cath labs in hospitals.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Yoqneam, Israel

Address	2 Hata'asia str
City	Yoqneam
Country	Israel
Zip	20692

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Nir Eliaz	CEO	VisiDome (CEO)
Prof. Moshe Flugelman	Co-Founder
Dr. Yael Nir	Co-Founder	novoGI (VP, Medical)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Co-Founder, ReLeaf
abC Defghij	Board Member	Co-Founder, ReLeaf
abC Defghij	Scientific Advisor	Chief of Cardiothoracic Surgery, Carmel Medical Center
abC Defghij	Scientific Advisor	Medical & Scientific Planning Manager, Meytav Technological Incubator
abC Defghij	Scientific Advisor	Medical Director, CVPath

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed - Extended

Nov. 06, 2007

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Investment Company	abCDe

Seed

Sep. 27, 2006

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Sep. 27, 2006

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe	R&D grant ($0.49m)

Last Updated:	abCDe
IVC Number:	abCDe